LEXINGTON, Mass., Dec. 17, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced ...
Shares of T2 Biosystems Inc. extended their losing streak to two days Wednesday despite the biotech clinching regulatory approval for a key diagnostic test. In a statement Tuesday, T2 Biosystems TTOO ...
T2 Biosystems won out over much larger companies like Boston Scientific and Medtronic to take the top spot in the Best Medical Technology category in the annual Prix Galien USA awards. When the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback